Arcutis Biotherapeutics, Inc. Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for January 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Moore Matthew Richard | SVP and Chief Busin ... | Option Exercise | A | 28.72 | 80,000 | 2,297,600 | 80,000 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Moore Matthew Richard | SVP and Chief Busin ... | Option Exercise | A | 28.72 | 80,000 | 2,297,600 | 80,000 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
| Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 24,440 | |
| Jan 14 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 183,118 | 181.9 K to 183.1 K (+0.67 %) |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
| Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,809 | 3,040 | 29,153 | |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 391 | 657 | 13,276 | |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Sell | S | 27.82 | 2,200 | 61,215 | 181,896 | 184.1 K to 181.9 K (-1.20 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,809 | 3,040 | 184,096 | 182.3 K to 184.1 K (+0.99 %) |
| Jan 06 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 391 | 657 | 182,287 | 181.9 K to 182.3 K (+0.21 %) |